Navigation Links
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Date:3/24/2009

ing a MACE rate of 3.6 percent (one patient) at two years. MACE is a composite clinical measure of safety and efficacy outcomes, defined as any event that resulted in re-treatment of the treated artery lesion (ischemia-driven target lesion revascularization), heart attack (myocardial infarction) or cardiac death.

"Based on the strong clinical outcomes from the first stage of Abbott's bioabsorbable device trial, interventional cardiologists have been eager to enroll their patients into the second stage of the trial," said John Ormiston, M.D., medical director at Mercy Hospital in Auckland, New Zealand, and co-principal investigator in the ABSORB trial. "If the bioabsorbable stent continues to perform well in this trial and subsequent larger trials with more complex narrowings, bioabsorbable device technology may become the new standard of care for patients with coronary artery disease."

Abbott is the only company with long-term clinical data (out to two years) evaluating the safety and performance of a fully bioabsorbable drug eluting coronary stent. Abbott's bioabsorbable everolimus eluting coronary device is made of polylactic acid, a proven biocompatible material that is commonly used in medical implants such as absorbable sutures. As with a metallic stent, Abbott's bioabsorbable device is designed to restore blood flow by propping a clogged vessel open, and to provide support until the blood vessel heals. Unlike a metallic stent, however, a bioabsorbable device is designed to be slowly metabolized by the body and completely absorbed over time.

"Abbott has been on the front lines of innovation in stent technology, and the fully bioabsorbable device is on track to become a clinical reality for patients," said John M. Capek, Ph.D., executive vice president, Medical Devices, Abbott. "Abbott is the furthest ahead in its clinical programs to bring a bioabsorbable drug eluting device to patients, and the company is com
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
2. Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
3. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
4. Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
5. Continuous Treatment With Abbotts HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
6. Abbotts Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
7. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
8. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
9. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
10. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DUBLIN , Apr. 17, 2015 Research and ... addition of the "Medical Oxygen Systems - Global ... This report analyzes the worldwide markets for Medical ... Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, ... analytics for the US, Canada , ...
(Date:4/17/2015)... 2015 Today, the Pharmaceutical Research and ... 12 biopharmaceutical companies as "We Work For Health ... and community service. Established in 2009, ... created by the biopharmaceutical industry to honor employees ... but have also shown an outstanding commitment to ...
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... of the "The Corporate Reputation of Pharma ... Edition " report to their offering. ... Perspective, is now in its fourth edition. This ... early 2015). For each annual Corporate Reputation report, ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... April 18, 2012 SurgLine International, Inc. (SGLN.PK) ... ("SurgLine") reported that the company has successfully completed its ... owned surgery center in the state of Indiana. The ... substantial savings over the competition. Toland ...
... Scripps Research Institute have shown that an injectable solution can ... findings could lead to human clinical trials of a treatment ... emergency. Cocaine is involved in more than 400,000 emergency-room visits ... States. The findings, reported recently in the journal ...
Cached Medicine Technology:SurgLine International, Inc. Update On New Revenues 2Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose 2Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose 3Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose 4
(Date:4/19/2015)... 2015 Autocarinsurancecheap.com has released a new ... offer financial protection for vulnerable family members. , ... insured dies or is disabled in an accident. The ... bought with an auto insurance plan. However, AD&D insurance ... to a life insurance policy. The newly blog post ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 Carinsurancehints.com has released ... who have to claim auto insurance benefits . ... pictures and gather all the necessary information for claiming auto ... a good insurance plan to cover most of the damages. ... insurance benefits for an accident. , Drivers can compare ...
(Date:4/19/2015)... April 19, 2015 Insurancecarsinsurance.com has released ... months and explaining how bad weather can affect ... have a big impact on auto insurance premiums. In ... auto insurance prices are higher than in other parts. ... will be during the next several months and what ...
(Date:4/19/2015)... A live auction will be held to ... hospital in Brooklyn, NY and other national consignors. Various types ... anesthesia, exam and much more. , The auction will ... at 9:00am CDT each day. The equipment is at their ... IL 60160. Anyone can participate in the auction including ...
(Date:4/19/2015)... MA (PRWEB) April 19, 2015 Family and ... Bowling for Brains in Memory of Brad Baddeley event ... Brain Aneurysm Foundation. , Bowling for Brains is cheduled to ... located 4700 Dudley Street in Lincoln, Nebraska. Participants may arrive ... 1:00 to 3:00pm. , The cost is only $4 per ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:An Online Guide About Claiming Auto Insurance Benefits After an Accident 2Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3
... Network, the prominent advocacy group launches the inaugural World ... site, www.worldmrsaday.org . MRSA activists ... and the community for a greater response to the ... alarming rate.MRSA Survivors Network, the official organization for World ...
... 5 The World Health Organization says a Swine ... already declared emergencies. Many experts believe the Federal government ... the outbreak takes on the public will become increasing ... of panic. Your only defense: to prepare your department ...
... Give Voice to Improving Quality Care and Quality Careers , ... for better senior living, celebrates National Nurse Week May 6-12, ... how to improve the business, the quality of care and ... Vigilan is offering an online and phone-based survey where ...
... Indiana University School of Medicine , the not-for-profit Taking Control ... for people living with diabetes on May 30 from 9 ... The TCOYD conference, lunch and health fair brings national and ... types of diabetes, those at risk for diabetes, and their ...
... Society of Cellular Therapy (ISCT) Demonstrating Potential to ... in TransplantationOLDSMAR, Fla., May 5 /PRNewswire-FirstCall/ -- ... new study showing that adding menstrual blood stem ... blood expands the number of progenitor cells (cells ...
... Inc. (Nasdaq: CYNO ), a ... light-based aesthetic treatment systems, today announced financial results for ... 2009 Financial Results , Consistent with Cynosure,s ... March 31, 2009 were $14.8 million, reflecting the continued ...
Cached Medicine News:Health News:MRSA Activists Rally For World MRSA Day 2Health News:Ready or Not - Flu Pandemic Has Arrived 2Health News:Vigilan Honors National Nurse Week in Assisted Living, Independent Living and Dementia Care 2Health News:Taking Control of Your Diabetes Conference Returns to Indianapolis to Bring Answers, Advocacy and Hope for People With Diabetes 2Health News:Taking Control of Your Diabetes Conference Returns to Indianapolis to Bring Answers, Advocacy and Hope for People With Diabetes 3Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 2Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 3Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 4Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 5Health News:Cynosure Reports Financial Results for the First Quarter of 2009 2Health News:Cynosure Reports Financial Results for the First Quarter of 2009 3Health News:Cynosure Reports Financial Results for the First Quarter of 2009 4Health News:Cynosure Reports Financial Results for the First Quarter of 2009 5Health News:Cynosure Reports Financial Results for the First Quarter of 2009 6Health News:Cynosure Reports Financial Results for the First Quarter of 2009 7Health News:Cynosure Reports Financial Results for the First Quarter of 2009 8Health News:Cynosure Reports Financial Results for the First Quarter of 2009 9Health News:Cynosure Reports Financial Results for the First Quarter of 2009 10
2.5 mm x 4 mm opening. Hexagonal handle....
Double-ended. Designated most popular model or size....
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size....
2 mm tip....
Medicine Products: